Nadia Waheed is Chief Medical Officer of OCULAR THERAPEUTIX, INC. Currently has a direct ownership of 206,805 shares of OCUL, which is worth approximately $2.07 Million. The most recent transaction as insider was on Jun 02, 2025, when has been sold 13,861 shares (Common Stock) at a price of $8.05 per share, resulting in proceeds of $111,581. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 207K
6.28% 3M change
45.98% 12M change
Total Value Held $2.07 Million

Nadia Waheed Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 02 2025
SELL
Open market or private sale
$111,581 $8.05 p/Share
13,861 Reduced 6.28%
206,805 Common Stock
Feb 11 2025
BUY
Grant, award, or other acquisition
-
79,000 Added 26.36%
220,666 Common Stock
Jun 01 2024
BUY
Grant, award, or other acquisition
-
141,666 Added 50.0%
141,666 Common Stock
NW

Nadia Waheed

Chief Medical Officer
Bedford, MA

Track Institutional and Insider Activities on OCUL

Follow OCULAR THERAPEUTIX, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCUL shares.

Notify only if

Insider Trading

Get notified when an Ocular Therapeutix, Inc insider buys or sells OCUL shares.

Notify only if

News

Receive news related to OCULAR THERAPEUTIX, INC

Track Activities on OCUL